Standalone figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95 | 95 | 80 | 57 | 77 | 108 | 68 | 112 | 91 | 99 | 111 | 135 | |
| COGS | 36 | 44 | 27 | 20 | 18 | 38 | 27 | 62 | 45 | 48 | 56 | 78 |
| Gross profit | 58 | 51 | 53 | 37 | 59 | 70 | 41 | 50 | 45 | 52 | 55 | 57 |
| 48 | 45 | 63 | 48 | 52 | 55 | 59 | 53 | 59 | 53 | 55 | 49 | |
| 10 | 7 | -9 | -10 | 7 | 15 | -19 | -3 | -14 | -1 | 0 | 7 | |
| OPM % | 10.5% | 7% | -11.5% | -18.4% | 8.8% | 14.2% | -27.4% | -2.7% | -15.1% | -1.4% | 0.3% | 5.4% |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Interest | 4 | 3 | 3 | 3 | 4 | 4 | 5 | 6 | 6 | 7 | 6 | 7 |
| 2 | 3 | 16 | 4 | 3 | 3 | 6 | 5 | 4 | 4 | 6 | 6 | |
| Profit before tax | 3 | 1 | -1 | -15 | 1 | 10 | -22 | -9 | -21 | -9 | -5 | 2 |
| Tax | 0 | 1 | 0 | -1 | 0 | 0 | -10 | -2 | -5 | -2 | -4 | 1 |
| Tax % | 0% | 59.8% | 1.5% | -8% | 0.8% | 0% | -43.8% | -24.2% | -25.3% | -22.3% | -96.1% | 30.5% |
| 3 | 0 | -1 | -14 | 1 | 10 | -12 | -7 | -16 | -7 | -0 | 1 | |
| PAT margin % | 3.4% | 0.5% | -1.7% | -24.2% | 1.7% | 8.9% | -18.3% | -6% | -17.2% | -7.4% | -0.2% | 1% |
| EPS (₹) | 0.5 | 0.1 | -0.2 | -2.3 | 0.2 | 1.6 | -2 | -1.1 | -2.6 | -1.2 | -0 | 0.2 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +94.1% | +32.3% | +7.1% | -36.4% | -19% | +13.9% | -15.5% | +97.3% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Dec 2019 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Vaccines | 55.52 | 1.05 | — | 176.16 |
| Formulations | 0 | 0 | — | 0 |
| Real Estate | 0 | 0 |
| +18.5% |
| -8.4% |
| +63.7% |
| +20% |
| PAT YoY % | — | -96.8% | — | -1,168.2% | -59.7% | +2,144.2% | — | — | -1,312.4% | -176.3% | — | — |
| — |
| 0 |
₹ crore by quarter